Ovulation suppression for endometriosis (Q24247932)

27 June 2017

1 reference

title

Ovulation suppression for endometriosis (English)

1 reference

27 June 2017

1 reference

E Hughes

1

1 reference

27 June 2017

D Fedorkow

series ordinal

2

1 reference

27 June 2017

J Collins

series ordinal

3

1 reference

27 June 2017

P Vandekerckhove

series ordinal

4

1 reference

27 June 2017

language of work or name

English

0 references

publication date

21 July 2003

0 references

1 January 2003

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

2000

0 references

published in

1 reference

27 June 2017

3

1 reference

27 June 2017

2

0 references

page(s)

CD000155

1 reference

Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial.

27 June 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high-dose medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Buserelin versus danazol in the treatment of endometriosis-associated infertility

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Nafarelin in the treatment of pelvic pain caused by endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Nafarelin versus danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Effects of nafarelin versus danazol on lipids and calcium metabolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

The effectivenss of danazol on subsequent fertility in minimal endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

A comparison of nafarelin acetate and danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

A quantitative overview of controlled trials in endometriosis-associated infertility.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: structural and ultrastructural study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Gestrinone versus danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Effects of 3 month therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

A comparative study of various dosages of danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

A Comparative Treatment Trial of Endometriosis Using the Gonadotrophin-releasing Hormone Agonist, Nafarelin, and the Synthetic Steroid, Danazol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Successful treatment of asymptomatic endometriosis: does it benefit infertile women?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

A multicentre comparative study of gestrinone and danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000155

7 January 2021

10.1002/14651858.CD000155

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3452825

OpenCitations bibliographic resource ID

27 June 2017

3452825

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference